Persistent URL of this record https://hdl.handle.net/1887/3750469
Documents
-
- Download
- jamaoncology_mazieres_2023_br_230010_1695221937.7181
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Tepotinib treatment in patients with MET exon 14-skipping non-small cell lung cancer: long-term follow-up of the VISION phase 2 nonrandomized clinical trial
- All authors
- Mazieres, J.; Paik, P.K.; Garassino, M.C.; X.N. le; Sakai, H.; Veillon, R.; Smit, E.F.; Cortot, A.B.; Raskin, J.; Viteri, S.; Wu, Y.L.; Yang, J.C.H.; Ahn, M.J.; Ma, R.; Zhao, J.; O'Brate, A.; Berghoff, K.; Bruns, R.; Otto, G.; Johne, A.; Felip, E.; Thomas, M.
- Date
- 2023-09-01
- Journal
- JAMA Oncology
- Volume
- 9
- Issue
- 9
- Pages
- 1260 - 1266